Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2022-11-04 00:00:00 ET · period of report 2022-11-03 · accession 0001415889-22-011079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-04 | 2022-11-03 | CAPR | Krasney Karen | EVP, GC | M - OptEx | $1.39 | +18.9K | 20.0K | +1,698% | +$26.3K |
| D | 2022-11-04 | 2022-11-03 | CAPR | Krasney Karen | EVP, GC | M - OptEx | $0.00 | -18.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-03 | M | A | 18,932 | $1.39 | 20,047 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-11-03 | M | D | 18,932 | $0.00 | 0 | D | $1.39 · — to 2022-11-13 | 18,932 Common Stock | (F1) This option was granted on November 13, 2012 and was previously reported as covering 189,320 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F2) 25% of the shares vested immediately, with the remainder vesting 1/36th on the first day of each month commencing December 1, 2012. |